Drugs / FF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01053988 | Oct 2009 → Feb 2011 | chronic obstructive pulmonary disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053988 ↗ |
| Route | Inhaled | “Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler” NCT01053988 ↗ |